Cord blood transplant shows promise for tough myeloma cases
NCT ID NCT03441958
First seen Mar 29, 2026 · Last updated May 17, 2026 · Updated 4 times
Summary
This study tested a new way to do cord blood transplants for people with high-risk multiple myeloma, a hard-to-treat blood cancer. Nineteen patients received a special expanded cord blood transplant to see if it was safe and could help control the disease. The goal was to reduce side effects like graft-versus-host disease and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond
Montreal, Quebec, H1T2M4, Canada
Conditions
Explore the condition pages connected to this study.